DRUG BRIGHT MINDS BIOSCIENCES INC.
Nasdaq · SEC CIK 1827401 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $9.79M 1 sales by 1 insiders
- Filings on record
- 3 since 2024-10-17, latest 2026-04-30 16:07
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Cormorant Asset Management, LP | Former 10% Owner | — | $9.79M |
Transactions 3
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-04-30 16:07 | 2026-04-28 | DRUG | Cormorant Asset Management, LP | Former 10% Owner | S - Sale | $89.50 | -109.3K | 950.0K | -10% | -$9.79M |
| I | 2024-11-06 | 2024-11-04 | DRUG | Cormorant Asset Management, LP | 10% | P - Purchase | $21.70 | +184.3K | 1.06M | +21% | +$4.00M |
| MI | 2024-10-17 | 2024-10-15+ | DRUG | Cormorant Global Healthcare Master Fund, LP | 10% | P - Purchase | $7.65 | +422.6K | 864.7K | +96% | +$3.23M |
Purchase Sale Sale after option exercise All abbreviations